EQRX
2 articles with EQRX
-
EQRx Scales Disruptive Model of Important New Medicines at Lower Prices with $500M Series B Financing
1/11/2021
Syndicate includes all Series A investors, preeminent life science and generalist funds, and market-leading health systems and payers
-
BioSpace is proud to present its NextGen Bio “Class of 2021,” a list of up-and-coming life sciences companies in North America that recently launched.